SCHEMBL4325966

SCHEMBL4325966

CCC(C)C(CC)NC(=O)c1ccc(C(=O)NC(CC)C(C)CC)c2c(C(=O)O)ccc(C(=O)O)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.44
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ ALDH1A1 P00352 4/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ LMNA P02545 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ TAS1R3 Q7RTX0 3/20 0.35
▸ TAS1R1 Q7RTX1 3/20 0.35
▸ CA2 P00918 2/20 0.35
▸ CA1 P00915 1/20 0.35
▸ FPR2 P25090 2/20 0.34
▸ TAS1R2 Q8TE23 2/20 0.34
▸ ATM Q13315 1/20 0.34
▸ ADRA1A P35348 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ MME P08473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30195119 0.78 MEN1 (0.54) CYP1A2MEN1KMT2AALDH1A1RAB9A
SCHEMBL18694713 0.75 TAS1R3 (0.47) CYP1A2MEN1KMT2AALDH1A1KDM4E
SCHEMBL3293927 0.75 CYP1A2 (0.52) CYP1A2MEN1KMT2AALDH1A1KDM4E
SCHEMBL4639171 0.73 MLYCD (0.52) CYP1A2MEN1KMT2AALDH1A1RAB9A
SCHEMBL823146 0.72 CYP1A2 (0.48) CYP1A2MEN1KMT2AALDH1A1KDM4E
SCHEMBL12706055 0.71 MEN1 (0.53) MEN1KMT2AALDH1A1RAB9ALMNA
SCHEMBL823157 0.71 CYP1A2 (0.56) CYP1A2MEN1KMT2AKDM4ELMNA
SCHEMBL9511408 0.71 CYP1A2 (0.39) CYP1A2MEN1KMT2AALDH1A1RAB9A
SCHEMBL8762296 0.70 MEN1 (0.60) MEN1KMT2AALDH1A1RAB9AKDM4E
SCHEMBL27201021 0.69 CYP1A2 (0.37) CYP1A2MEN1KMT2AALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7491989-B2 Positive charging photoreceptor XEROX CORPORATION (US) 2009-02-17 — — US disclosed
EP-1640808-B1 Photoconductive imaging members XEROX CORP (US) 2008-07-09 — — EP disclosed
US-7312007-B2 Hole blocking layer containing a metal oxide (TiO2) having an aspect ratio of 4-5 and powder resistance of 1x104-6x104 ohm/cm when applied at a pressure of 650-50 kg/cm2 and a binder; photogenerating layer; and a charge transport layer XEROX CORPORATION (US) 2007-12-25 — — US disclosed
US-20070023747-A1 Positive charging photoreceptor XEROX CORPORATION (US) 2007-02-01 — — US disclosed
US-7070894-B2 Photoconductive imaging members XEROX CORPORATION (US) 2006-07-04 — — US disclosed
US-20060057480-A1 Photoconductive imaging members XEROX CORPORATION 2006-03-16 — — US disclosed
US-20050175913-A1 Photoconductive imaging members XEROX CORPORATION 2005-08-11 — — US disclosed
US-6858363-B2 Photoconductive imaging members XEROX CORPORATION (US) 2005-02-22 — — US disclosed
US-20040197686-A1 Prevents, or minimizes dark injection, and wherein the resulting photoconducting members possess, for example, excellent photoinduced discharge characteristics, cyclic and environmental stability and acceptable charge deficient spot XEROX CORPORATION 2004-10-07 — — US disclosed
Send feedback